Bixiye
QP23-18 Pharmacy Benefit Exclusion for Crysvita
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2018
Natiijooyinka Raadinta
Soo bandhiga 2861 - 2870 ee natiijooyinka 3688
Bixiye
QP36-18 Pre-Admission Notification Update Effective May 21, 2018
Taariikhda uu dhaqangalayo Barnaamijka: May 18, 2018
Bixiye
QP14-18 Pharmacy Benefit Exclusion for Fasenra
Taariikhda uu dhaqangalayo Barnaamijka: 19, Feb 2018
Bixiye
QP79-18 Addition of Drug to the Hereditary Angioedema Prior Authorization with Quantity Limit Program
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 21, 2018
Bixiye
QP77-18 Pharmacy Benefit Exclusion for Onpattro (patisiran) Lipid Complex Intravenous (IV) Injection
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 11, 2018
Bixiye
QP57-18 New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary Angioedema
Taariikhda dhaqangalka Barnaamijka: Jul 19, 2018
Bixiye
QP39-18 Provider Cost Data Update
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2018
Bixiye
QP44-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Lyrica CR (pregabalin Extended Release)
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2018
Bixiye
QP40-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Selective Serotonin Inverse Agonist (SSIA)
Taariikhda uu dhaqangalayo Barnaamijka: May 31, 2018
Bixiye
QP30-18 Subscriber Identification (ID) Cards
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 27, 2018